LSC
NEOS

Lyon Street Capital’s Neos Therapeutics, Inc NEOS Stock Holding History

Lyon Street Capital’s Portfolio NEOS Stock Details NEOS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-364,697
Closed -$1.77M – 63
2018
Q3 		$1.77M Sell
364,697
-675,964
-65% -$3.83M 1.1% 31
2018
Q2 		$6.5M Sell
1,040,661
-414,953
-29% -$3.09M 2.31% 13
2018
Q1 		$12.1M Buy
1,455,614
+672,031
+86% +$6.42M 3.89% 6
2017
Q4 		$7.99M Buy
783,583
+558,117
+248% +$5.36M 2.67% 10
2017
Q3 		$2.06M Buy
+225,466
New +$1.71M 0.8% 48

Other funds holding NEOS

NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JGC
J. Goldman & Co New York $3.44B AUM 33.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Lyon Street Capital's NEOS Position: Q4 2018 in Review

Lyon Street Capital sold out of Neos Therapeutics, Inc (NEOS) in Q4 2018, closing a stake of 364,697 shares — an estimated $1.77M sold.

Lyon Street Capital first reported a position in NEOS in Q3 2017 and held it in 5 quarters. The position peaked at $12.1M in Q1 2018. 63 funds tracked by Wall St. Rank hold NEOS as of Q4 2018.

  • Lyon Street Capital reported no remaining Neos Therapeutics, Inc position as of Q4 2018 after selling out during the quarter.
  • Lyon Street Capital sold 364,697 Neos Therapeutics, Inc shares in Q4 2018, an estimated $1.77M.
  • Lyon Street Capital first reported a position in Neos Therapeutics, Inc in Q3 2017 and held it in 5 quarters.
  • Lyon Street Capital's Neos Therapeutics, Inc position peaked at $12.1M in Q1 2018.
  • 63 funds tracked by Wall St. Rank held Neos Therapeutics, Inc as of Q4 2018.

Based on Lyon Street Capital's 13F filing for Q4 2018, filed 14 Feb 2019.